Prevnar-13 stronger than older version of vaccine, data show

Results from four European trials suggest that Wyeth's Prevnar-13 can provide stronger protection against pneumococcal disease in young children compared with Prevnar, an older version of the vaccine. A Wyeth official said Prevnar-13 can work against 19A, a form of the bacterium Streptococcus pneumoniae that causes the most serious kind of pneumococcal disease and is resistant to antibiotics in some cases.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA